News

Researchers have developed an oral form of insulin that lowers glucose levels in animal models. The oral insulin, encased in a nano-carrier that delivers insulin to the liver, is expected to begin human trials in 2025.

How, exactly, DMT alters brain function to produce positive effects observed in clinical trials is not yet clear, though a study from scientists at Imperial College London has shed some light.

Purdue researchers have created molecular compounds to inhibit protein aggregation linked with Alzheimer’s disease, Parkinson’s disease and Type 2 diabetes.

A traditional African psychedelic drug reduced symptoms of veterans’ brain injury in a small clinical study published in Nature Medicine.

Scientists have developed a strange new material that can quickly flip between a liquid and a solid state – all thanks to magnets.

Structural insights into a potent antimalarial drug candidate’s interaction with the malaria parasite Plasmodium falciparum have paved the way for drug-resistant malaria therapies, according to a new study.

New research has been published that identifies positive steps towards a better understanding of antimicrobial resistance (AMR), specifically in hospital-acquired pneumonia (HAP).

Research suggests that a wearable patch featuring electrically triggered microneedles for on-demand drug delivery could be the next frontier in treatment of neurodegenerative disorders and neurological injuries.

A drug designed to slow or halt progression of a specific type of heart failure – transthyretin amyloid cardiomyopathy – has been shown to be safe and effective in a phase 3 trial.

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people.